CAMSING HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.07 SGD | +9.18% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: Januar | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 27.9 | 32.1 | 32.1 | 32.1 | 32.1 | 32.1 |
| Enterprise Value (EV) 1 | 26.25 | 34.16 | 36.9 | 34.85 | 35.53 | 38.41 |
| P/E ratio | 527 x | -4.89 x | -5.88 x | -38.8 x | -24.2 x | -13.4 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.87 x | 3.83 x | 4.39 x | 5.64 x | 5.8 x | 5.26 x |
| EV / Revenue | 1.76 x | 4.07 x | 5.05 x | 6.12 x | 6.43 x | 6.29 x |
| EV / EBITDA | 167 x | -12 x | -10.5 x | -22.5 x | -20.7 x | -20 x |
| EV / FCF | -37.2 x | 1,089 x | 9.52 x | 20.6 x | 35.6 x | -78 x |
| FCF Yield | -2.69% | 0.09% | 10.5% | 4.86% | 2.81% | -1.28% |
| Price to Book | 2.52 x | 7.64 x | -27 x | -15.9 x | -9.64 x | -5.6 x |
| Nbr of stocks (in thousands) | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
| Reference price 2 | 0.9300 | 1.070 | 1.070 | 1.070 | 1.070 | 1.070 |
| Announcement Date | 11/05/18 | 16/12/21 | 17/02/22 | 14/04/22 | 23/08/22 | 16/05/23 |
1SGD in Million2SGD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Januar | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 14.91 | 8.386 | 7.308 | 5.69 | 5.53 | 6.103 |
| EBITDA 1 | 0.157 | -2.846 | -3.512 | -1.551 | -1.719 | -1.923 |
| EBIT 1 | -0.256 | -3.272 | -3.878 | -1.757 | -1.821 | -2.016 |
| Operating Margin | -1.72% | -39.02% | -53.07% | -30.88% | -32.93% | -33.03% |
| Earnings before Tax (EBT) 1 | 0.122 | -6.571 | -5.458 | -0.829 | -1.349 | -2.402 |
| Net income 1 | 0.053 | -6.57 | -5.458 | -0.828 | -1.328 | -2.405 |
| Net margin | 0.36% | -78.34% | -74.69% | -14.55% | -24.01% | -39.41% |
| EPS 2 | 0.001766 | -0.2190 | -0.1819 | -0.0276 | -0.0443 | -0.0801 |
| Free Cash Flow 1 | -0.7048 | 0.0314 | 3.875 | 1.695 | 0.9969 | -0.4922 |
| FCF margin | -4.73% | 0.37% | 53.03% | 29.79% | 18.03% | -8.07% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/05/18 | 16/12/21 | 17/02/22 | 14/04/22 | 23/08/22 | 16/05/23 |
1SGD in Million2SGD
Estimates
Balance Sheet Analysis
| Fiscal Period: Januar | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 2.06 | 4.8 | 2.75 | 3.43 | 6.31 |
| Net Cash position 1 | 1.65 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.7238 x | -1.366 x | -1.774 x | -1.996 x | -3.279 x |
| Free Cash Flow 1 | -0.7 | 0.03 | 3.88 | 1.7 | 1 | -0.49 |
| ROE (net income / shareholders' equity) | 0.06% | -86.2% | -363% | 51.7% | 49.6% | 53% |
| ROA (Net income/ Total Assets) | -1% | -16.6% | -32.5% | -21.6% | -30% | -32.7% |
| Assets 1 | -5.293 | 39.52 | 16.79 | 3.832 | 4.432 | 7.366 |
| Book Value Per Share 2 | 0.3700 | 0.1400 | -0.0400 | -0.0700 | -0.1100 | -0.1900 |
| Cash Flow per Share 2 | 0.1700 | 0.0500 | 0.0200 | 0.0200 | 0.0200 | 0.0100 |
| Capex 1 | 0.82 | 0.6 | 0.18 | 0.01 | 0.03 | 0.15 |
| Capex / Sales | 5.51% | 7.2% | 2.5% | 0.11% | 0.6% | 2.51% |
| Announcement Date | 11/05/18 | 16/12/21 | 17/02/22 | 14/04/22 | 23/08/22 | 16/05/23 |
1SGD in Million2SGD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 23.81M | |
| -.--% | 843M | |
| +0.79% | 672M | |
| +33.39% | 250M | |
| 0.00% | 145M | |
| +102.17% | 56.31M |
- Stock Market
- Equities
- BAC Stock
- Financials Camsing Healthcare Limited
